Regotab®
Tablet
Brand Name:
Regotab®40
Generic Name:
Regorafenib
Strength:
40mg
Description:
Tablet
Pack Size:
28's
* Storage Conditions: Store at or below 25° C temperature. Keep away from light & wet place. Keep out of the reach of children.
Approved Indications of REGOTAB
Regotab® is a kinase inhibitor indicated for the treatment of patients with:
- Metastatic colorectal cancer (CRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an antiVEGF therapy, and, if RAS wild-type, an anti-EGFR therapy.
- Locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with Imatinib mesylate and Sunitinib malate.
- Hepatocellular carcinoma (HCC) who have been previously treated with Sorafenib